Literature DB >> 28004170

Uterine Artery Embolization for Retained Products of Conception with Marked Vascularity: A Safe and Efficient First-Line Treatment.

Paul Bazeries1, Francine Paisant-Thouveny2, Sultan Yahya2, Antoine Bouvier2, Cosmina Nedelcu2, Francoise Boussion3, Loic Sentilhes3, Serge Willoteaux2, Christophe Aubé2.   

Abstract

OBJECTIVE: To report our clinical practice regarding a case series of retained products of conception (RPOC) with marked vascularity (MV) managed with selective uterine artery embolization (UAE) as first-line treatment.
METHODS: This was a monocentric, retrospective study of 31 consecutive cases of RPOC with MV diagnosed by Doppler ultrasound in the context of postpartum/postabortal bleeding. The primary outcome was the absence of rebleeding following embolization.
RESULTS: RPOC with MV occurred after abortion in 27 out of 31 patients (87%). The time elapsed between delivery/abortion and UAE ranged from 1 to 210 days (mean 55.7 ± 45 days). Primary clinical success was achieved in 23 women (74.2%) following a single embolization. In total, 27 out of 31 women (87%) had been exclusively managed by UAE with conservative success. Although procedural success was achieved in this number, six women had a further procedure to evacuate RPOC despite procedural success. Large uterine arteriovenous (AV) shunts associated with RPOC were observed in five cases (16.1%), among which two were successfully treated after a single UAE and one after two UAEs, while hysterectomy was performed in the last two cases despite two and three UAE procedures respectively. RPOC was histologically proven in ten cases (32.2%) including four out of five cases of uterine AV shunt.
CONCLUSION: RPOC with MV can present with large uterine AV shunt, particularly in case of late management. Uterine artery embolization is an effective and safe first-line treatment, and should be evaluated for this indication in larger prospective trials.

Entities:  

Keywords:  Postpartum hemorrhage; Retained products of conception; Uterine arterial embolization; Uterine arteriovenous malformation

Mesh:

Year:  2016        PMID: 28004170     DOI: 10.1007/s00270-016-1543-7

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  3 in total

1.  Predictive factors for massive hemorrhage in women with retained products of conception: a prospective study.

Authors:  Reina Sonehara; Tomoko Nakamura; Akira Iwase; Kazuki Nishida; Sachiko Takikawa; Mayuko Murakami; Sayako Yoshita; Ayako Muraoka; Natsuki Miyake; Natsuki Nakanishi; Satoko Osuka; Maki Goto; Hiroaki Kajiyama
Journal:  Sci Rep       Date:  2022-07-13       Impact factor: 4.996

2.  Spontaneous Resolution of an Acquired Uterine Arteriovenous Malformation in an Elderly Primigravida.

Authors:  Viola Ghizzoni; Silvia Gabbrielli; Luca Mannini; Flavia Sorbi; Irene Turrini; Giulia Fantappiè; Dora Pavone; Massimiliano Fambrini; Ivo Noci
Journal:  Am J Case Rep       Date:  2018-09-27

3.  The RPOC long axis is a simple indicator for predicting the need of invasive strategies for secondary postpartum hemorrhage in either post-abortion or post-partum women: a retrospective case control study.

Authors:  Mariya Kobayashi; Satoshi Nakagawa; Yoko Kawanishi; Tatsuo Masuda; Takahide Maenaka; Aska Toda; Tatsuya Miyake; Kosuke Hiramatsu; Ai Miyoshi; Kazuya Mimura; Toshihiro Kimura; Masayuki Endo; Tadashi Kimura
Journal:  BMC Pregnancy Childbirth       Date:  2021-09-24       Impact factor: 3.007

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.